The makers of defective hip implants that catastrophically failed and increased the risk of metallosis in patients announced established a settlement program to address civil complaints against the defective products.
It is estimated that Stryker and Howmedica Osteonics will be paying about $1.4 billion to patients who qualify under the program. The base compensation for each patient is $300,000, which may be higher depending on the extent of the damage and the consequences to the patient and other family members. The announcement was made on November 4, 2014. The deadline for registration to participate in the program was set for December 14, 2014.
The defective products in this landmark settlement program are the Stryker Rejuvenate and ABG II hip replacement devices. The initial recall was made in the first half of 2012 when numerous reports of adverse events started pouring in from patients that required revision or replacement surgery, or suffered significant pain and problems caused by the implants. The manufacturers are under the hammer for defect in design and failing to carry out adequate testing to ensure the safety of their patients.
According to the website of law firm Williams Kherkher, it may be too late to participate in the settlement program, but patients implanted with either device may still be eligible to file a defective medical device lawsuit against the manufacturers. Patients react differently under the same circumstances, and some may have a delayed reaction to the devices. Those that have begun exhibiting the following symptoms of metallosis after the deadline for registration has passed may still make a claim:
- Loss of concentration
- Loss of hearing
- Pain in the groin area
- Poor memory
You should act on this right away before you develop complications. Have your doctor check on you, and consult with a defective hip implant lawyer in your state for assistance. Your journey is just beginning.